Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	Radiographic Horizontal Bone Gain	Baseline to 6 months postoperatively	The radiographic horizontal bone gain will be assessed by comparing the horizontal alveolar ridge width before guided bone regeneration and at 6 months postoperatively using standardized CBCT measurements at predetermined reference points.
Secondary	Clinical Horizontal Bone Gain	Baseline to 6 months postoperatively	Clinical horizontal bone gain will be assessed by measuring the alveolar ridge width at standardized reference points using a periodontal caliper before surgery and at 6 months postoperatively
Secondary	Quality of Bone	6 months postoperatively, at implant placement	The quality of the regenerated bone will be evaluated histologically from a core biopsy obtained from the augmented site at the time of implant placement. Histological assessment will characterize the quality and composition of the regenerated bone
Secondary	Vertical Bone Gain	Baseline to 6 months postoperatively	Vertical bone gain will be assessed radiographically by comparing standardized CBCT measurements obtained before guided bone regeneration and at 6 months postoperatively.
Secondary	Keratinized Tissue Width	Baseline and 3 and 6 months after augmentation	The width of keratinized tissue will be measured clinically at standardized sites using a UNC-15 graduated periodontal probe at baseline and at 6 months postoperatively.
Secondary	Soft Tissue Thickness	Baseline and 3 and 6 months after augmentation	Soft tissue thickness will be measured at standardized sites using a needle with a stopper before treatment and at 6 months postoperatively.
Secondary	Incidence of Postoperative Infection	1 week, 2 weeks, and 6 months after augmentation	The incidence of postoperative infection will be recorded based on the presence or absence of clinical signs of infection, including swelling, suppuration, pain, or other clinical findings requiring intervention or antibiotic treatment.
Secondary	Postoperative Edema	1 week and 2 weeks after augmentation	Postoperative facial edema will be assessed using a flexible measuring thread at standardized facial reference points and recorded as the change in facial measurements following surgery
Secondary	Procedural Time	During the surgical procedure	The total procedural time will be measured from the beginning of the surgical procedure until completion of wound closure using a stopwatch.
Secondary	Postoperative Pain	Day 1 to Day 14 after augmentation	Patient-reported postoperative pain will be assessed using a Visual Analog Scale (VAS) during the postoperative follow-up period.
Secondary	Implant Primary Stability	6 months postoperatively, at implant placement	Implant primary stability will be assessed at the time of implant placement using resonance frequency analysis and recorded as the Implant Stability Quotient (ISQ).

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07883603/registered

API reference For AI assistants